Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: J Public Econ. 2013 Jan;97:327–336. doi: 10.1016/j.jpubeco.2012.10.003

Figure 1.

Figure 1

Number of drugs entering clinical trials by phase and year, analytic panel of 49 therapeutic classes, 1998 – 2010

Source: Authors’ calculations based on pharmaprojects data.

Note: Only includes trials for analytic panel of Pharmaprojects classes matched to Multum therapeutic categories.